Adverse Drug Reactions among Children with Tuberculosis in Tashkent, Uzbekistan, 2019
Open Access
- 16 July 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (14) , 7574
Abstract
The treatment of childhood tuberculosis can be challenging due to the lack of pediatric drug formulations and monitoring of drug-toxicity in routine settings. There are no published studies from Uzbekistan on the adverse drug reactions (ADR) associated with anti-tuberculosis treatment in children. In this study, we aimed to investigate the ADR associated with anti-tuberculosis treatment in children. This was a cohort study using secondary program data of children treated at the city and regional tuberculosis clinics in Tashkent, Uzbekistan. Of the 302 patients evaluated, 135 (44.7%) reported ADR. New tuberculosis was registered in 277 (92%) patients and 262 (87%) had extrapulmonary tuberculosis. Factors associated with ADR included treatment at a regional hospital (adjusted odds ratio, aOR = 1.75; p = 0.026), female sex (aOR = 2.2; p = 0.004), and treatment with second-line drugs (aOR = 8.82; p < 0.001). The most common ADRs were gastrointestinal disorders (28.5%) followed by hepatitis (8.9%) and dermatologic reactions (8.6%). Most of the ADRs were mild (55.6%) or moderate (43.7%), only one child had severe ADR. Patients with the identified risk factors should be closely monitored during the treatment. We also recommend expansion of ADR surveillance throughout the country for more representative data in the future.Keywords
Funding Information
- World Health Organization (N/A)
- German KfW Development Bank (n/A)
This publication has 21 references indexed in Scilit:
- Mechanism of isoniazid‐induced hepatotoxicity: then and nowBritish Journal of Clinical Pharmacology, 2016
- Pediatric tuberculosis drug market: an insider perspective on challenges and solutionsThe International Journal of Tuberculosis and Lung Disease, 2015
- Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis PatientsTuberculosis Research and Treatment, 2014
- Tuberculosis in ChildrenCold Spring Harbor Perspectives in Medicine, 2014
- Risk factors associated with adverse drug reactions in hospitalised children: international multicentre studyEuropean Journal of Clinical Pharmacology, 2011
- The pharmacokinetics and pharmacodynamics of rifampicin in adults and children in relation to the dosage recommended for childrenTuberculosis, 2011
- Efeitos adversos causados pelo novo esquema de tratamento da tuberculose preconizado pelo Ministério da Saúde do BrasilJornal Brasileiro de Pneumologia, 2010
- Review Article: Adverse drug reactions in children: Types, incidence and risk factorsNigerian Journal of Paediatrics, 2008
- A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment systemInternational Journal of Medical Informatics, 2008
- Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosisEuropean Respiratory Journal, 1996